Policresulen/Dibucaine hydrochloride

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NamePolicresulen/Dibucaine hydrochloride
Drug Alias Name复方聚甲酚磺醛栓
ClassificationSmall molecules
Mechanisms of ActionSodium channel protein type V alpha subunit blockersSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type V alpha subunitSodium channel protein type X alpha subunit
Therapy Area/IndicationsHemorrhoids
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Dibucaine hydrochloridePolicresulen
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Yaolian Technology Innovation Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong Chengchuang Pharmaceutical Technology Development Co Ltd
Active IndicationsN/A
Inactive IndicationsHemorrhoids

Other Information

ATC CodeN/A
Related LinksN/A